This figure is not designed to be applied rigidly but to be used as a broad construct to guide clinical decision-making and engage in shared decision-making in people with type 1 and type 2 diabetes
Still, the GLP-1 landscape can be difficult to navigate
Some individuals prefer to avoid synthetic medications whenever possible, while others simply want to know exactly what they are putting into their bodies
Our team will review all submissions and contact suitable partners to discuss territory availability and next steps
Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet
Key highlights Retatrutide is a next-generation weight loss medication that activates GLP-1, GIP, and glucagon receptors simultaneously to promote appetite suppression, improve metabolic health, and increase energy expenditure